Holcombe E. Grier

18.9k total citations · 4 hit papers
145 papers, 11.7k citations indexed

About

Holcombe E. Grier is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Neurology. According to data from OpenAlex, Holcombe E. Grier has authored 145 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 48 papers in Surgery and 37 papers in Neurology. Recurrent topics in Holcombe E. Grier's work include Sarcoma Diagnosis and Treatment (76 papers), Neuroblastoma Research and Treatments (34 papers) and Testicular diseases and treatments (18 papers). Holcombe E. Grier is often cited by papers focused on Sarcoma Diagnosis and Treatment (76 papers), Neuroblastoma Research and Treatments (34 papers) and Testicular diseases and treatments (18 papers). Holcombe E. Grier collaborates with scholars based in United States, Canada and Switzerland. Holcombe E. Grier's co-authors include Jane C. Weeks, Joanne Wolfe, Mark Krailo, Mark C. Gebhardt, Jennifer W. Mack, Antonio R. Pérez‐Atayde, Michael P. Link, Paul A. Meyers, Paul S. Dickman and Ezekiel J. Emanuel and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Holcombe E. Grier

144 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

2003 948 citations Holcombe E. Grier, Mark Krailo et al. profile →
Symptoms and Suffering at the End of Life in Children with Cancer

2000 822 citations Holcombe E. Grier et al. profile →
Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

2008 520 citations Paul A. Meyers, Cindy L. Schwartz et al. Journal of Clinical Oncology profile →
Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

2012 482 citations Richard B. Womer, Daniel C. West et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Holcombe E. Grier

Since Specialization

Citations

This map shows the geographic impact of Holcombe E. Grier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holcombe E. Grier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holcombe E. Grier more than expected).

Fields of papers citing papers by Holcombe E. Grier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holcombe E. Grier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holcombe E. Grier. The network helps show where Holcombe E. Grier may publish in the future.

Co-authorship network of co-authors of Holcombe E. Grier

This figure shows the co-authorship network connecting the top 25 collaborators of Holcombe E. Grier. A scholar is included among the top collaborators of Holcombe E. Grier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holcombe E. Grier. Holcombe E. Grier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031 2023 ·Journal of Clinical Oncology ·Thomas F. Cash, Mark Krailo, Allen Buxton, Bruce Pawel, John H. Healey, Odion Binitie, Karen J. Marcus, Holcombe E. Grier, Patrick J. Grohar, Damon R. Reed, Aaron R. Weiss, Richard Görlick, Katherine A. Janeway, Steven G. DuBois, Richard B. Womer	6
2	Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review 2020 ·Pediatric Blood & Cancer ·Kevin Campbell, David S. Shulman, Holcombe E. Grier, Steven G. DuBois	16
3	Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group 2016 ·Clinical Cancer Research ·Kieuhoa T. Vo, (unknown), C. Lorrie Epling, Elizabeth Sinclair, Douglas S. Hawkins, Holcombe E. Grier, Katherine A. Janeway, Phillip Barnette, (unknown), Mark Krailo, Donald A. Barkauskas, Katherine K. Matthay, Richard B. Womer, Richard Görlick, Stephen L. Lessnick, Crystal L. Mackall, Steven G. DuBois	17
4	Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group breakdown → 2012 ·Journal of Clinical Oncology ·Richard B. Womer, Daniel C. West, Mark Krailo, Paul S. Dickman, Bruce Pawel, Holcombe E. Grier, Karen J. Marcus, Scott L. Sailer, John H. Healey, John P. Dormans, Aaron R. Weiss	482
5	Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study 2012 ·Pediatric Blood & Cancer ·Stephen X. Skapek, James R. Anderson, David A. Hill, David W. Henry, Sheri L. Spunt, William H. Meyer, Simon C. Kao, Fredric A. Hoffer, Holcombe E. Grier, Douglas S. Hawkins, R. Beverly Raney	90
6	Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group 2012 ·Journal of Clinical Oncology ·(unknown), Paul A. Meyers, Holcombe E. Grier, Mark L. Bernstein, Richard Görlick, Steven E. Lipshultz, Mark Krailo, Meenakshi Devidas, Donald A. Barkauskas, Gene P. Siegal, William S. Ferguson, G. Douglas Letson, Karen J. Marcus, Allen M. Goorin, (unknown), Neyssa Marina	184
7	Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study 2009 ·Journal of Clinical Oncology ·Linda Granowetter, Richard B. Womer, Meenakshi Devidas, Mark Krailo, Chenguang Wang, Mark L. Bernstein, Neyssa Marina, Patrick J. Leavey, Mark C. Gebhardt, John H. Healey, Robert C. Shamberger, Allen M. Goorin, James S. Miser, James S. Meyer, Carola A.S. Arndt, Scott L. Sailer, Karen J. Marcus, Elizabeth J. Perlman, Paul S. Dickman, Holcombe E. Grier	235
8	Sinonasal and Laryngeal Carcinoma in Children: Correlation of Imaging Characteristics with Clinicopathologic and Cytogenetic Features 2009 ·American Journal of Neuroradiology ·Caroline D. Robson, Reza Rahbar, Sara O. Vargas, Karen J. Marcus, Jennifer W. Mack, Greg R. Licameli, Holcombe E. Grier	5
9	Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group breakdown → 2008 ·Journal of Clinical Oncology ·Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, John H. Healey, Mark L. Bernstein, Donna L. Betcher, William S. Ferguson, Mark C. Gebhardt, Allen M. Goorin, Michael B. Harris, Eugenie S. Kleinerman, Michael P. Link, Helen Nadel, Michael L. Nieder, Gene P. Siegal, Michael A. Weiner, Robert J. Wells, Richard B. Womer, Holcombe E. Grier	520
10	Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group 2006 ·Journal of Clinical Oncology ·Torunn I. Yock, Mark Krailo, Christopher Fryer, Sarah S. Donaldson, James S. Miser, Zhengjia Chen, Mark L. Bernstein, Fran Laurie, Mark C. Gebhardt, Holcombe E. Grier, Nancy J. Tarbell	100
11	BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. 2003 ·Cancer Research ·Christopher A. French, I Miyoshi, Ichiro Kubonishi, Holcombe E. Grier, Antonio R. Pérez‐Atayde, Jonathan A. Fletcher	380
12	Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall 2003 ·Annals of Surgery ·Robert C. Shamberger, Michael P. LaQuaglia, Mark C. Gebhardt, James R. Neff, Nancy J. Tarbell, Karen Marcus, Scott L. Sailer, Richard B. Womer, James S. Miser, Paul S. Dickman, Elizabeth J. Perlman, Meenakshi Devidas, Stephen B. Linda, Mark Krailo, Holcombe E. Grier, Linda Granowetter	75
13	Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial 2001 ·The American journal of pediatric hematology/oncology ·William S. Ferguson, Michael B. Harris, Allen M. Goorin, Mark C. Gebhardt, Michael P. Link, Stephen J. Shochat, Gene P. Siegal, Meenakshi Devidas, Holcombe E. Grier	52
14	High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood 2001 ·Cancer ·Lisa B. Kenney, Marc R. Laufer, Frederick D. Grant, Holcombe E. Grier, (unknown)	222
15	Late Events in Pediatric Patients With Ewing Sarcoma/Primitive Neuroectodermal Tumor of Bone 1999 ·Journal of Pediatric Hematology/Oncology ·Thomas W. McLean, (unknown), Mary Lynn Young, Karen Marcus, (unknown), Mark C. Gebhardt, Howard J. Weinstein, Antonio R. Pérez‐Atayde, Holcombe E. Grier	41
16	Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study. 1998 ·Journal of Clinical Oncology ·(unknown), Daniel T. Casto, Paul J. Thomas, Steven Weitman, C. Kretschmar, Holcombe E. Grier, C B Pratt, Ronald L. Dubowy, Mark Bernstein, Susan M. Blaney, Teresa J. Vietti	15
17	Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five-Day Course in Children with Refractory Solid Tumors 1996 ·Journal of Pediatric Hematology/Oncology ·David G. Tubergen, Clinton F. Stewart, Charles B. Pratt, William C. Zamboni, Naomi Winick, Victor M. Santana, (unknown), Joanne Kurtzberg, Beverly Bell, Holcombe E. Grier, Teresa J. Vietti	112
18	Patient-controlled analgesia for mucositis pain in children: A three-period crossover study comparing morphine and hydromorphone 1996 ·The Journal of Pediatrics ·John J. Collins, (unknown), Holcombe E. Grier, Constance S. Houck, Howard T. Thaler, Howard J. Weinstein, (unknown), Charles B. Berde	79
19	A 10-year experience of pediatric brachytherapy 1995 ·International Journal of Radiation OncologyBiologyPhysics ·Elizabeth Healey, Robert C. Shamberger, Holcombe E. Grier, Jay S. Loeffler, Nancy J. Tarbell	32
20	Percutaneous biopsy of peripheral primitive neuroectodermal tumors and Ewing's sarcomas for cytogenetic analysis. 1994 ·American Journal of Roentgenology ·Fredric A. Hoffer, (unknown), Jonathan A. Fletcher, Holcombe E. Grier	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact